Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/INDEX-PHARMACEUTICALS-HOL-39436573/news/InDex-Pharmaceuticals-Receives-FDA-Clearance-to-start-the-Phase-III-Study-CONCLUDE-with-Cobitolimod-36236507/?utm_source=whatsapp&utm_medium=social&utm_campaign=share